The next chapter for group B meningococcal vaccines
The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...
Main Authors: | Wang, N, Pollard, A |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Taylor and Francis
2017
|
相似書籍
-
Group B meningococcal vaccine science and policy
由: Drysdale, SB, et al.
出版: (2015) -
Group B meningococcal vaccine: Recommendations for UK use
由: Pollard, A, et al.
出版: (2014) -
Group B meningococcal vaccine: recommendations for UK use.
由: Pollard, A, et al.
出版: (2014) -
Four component meningococcal capsular Group B vaccine in preterm infants.
由: Sadarangani, M, et al.
出版: (2017) -
Meningococcal vaccines.
由: Rüggeberg, J, et al.
出版: (2004)